LINEZOLID
Drugs in Pregnancy and Lactation.
"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
Name: LINEZOLID
Class: Anti-infective
Risk Factor: CM
Fetal Risk Summary
Linezolid, is a synthetic, oxaxolidinone class, antibacterial agent that is indicated for the treatment of gram positive bacteria, including vancomycin-resistant enterococcus (VRE). It is available in both oral and IV formulations.
Reproduction studies have been conducted in pregnant mice and rats (1). No evidence of teratogenicity was seen in mice and rats at doses that were 4 and 1 times the expected human exposure based on area under the plasma concentration curve (EHE), respectively. However, in mice, embryo and fetal toxicity (embryo death, including total litter loss, decreased fetal weight, and an increased incidence of costal cartilage fusion) and maternal toxicity (clinical signs and reduced weight gain) were seen at this dose. In pregnant rats, doses 0.13 and 0.64 times the EHE resulted in slight fetal toxicity (reduced fetal weight and ossification of sternebrae). The higher dose (0.64 times the EHE) caused slight maternal toxicity consisting of reduced body weight gain. When this dose was given during pregnancy and lactation, pup survival was decreased on postnatal days 1 to 4. In addition, when surviving pups reached maturity and were mated, they had decreased fertility as evidenced by an increase in preimplantation loss (1).
It is not known if linezolid crosses the human placenta. The molecular weight (about 337) is low enough that transfer to the fetus should be expected.
No reports describing the use of linezolid during human pregnancy have been located. Because of the lack of human pregnancy data, other antibiotics with this experience should be used if possible. If no other alternatives are available and linezolid must be used, the maternal benefit appears to outweigh the unknown fetal risk.
Breast Feeding Summary
Linezolid and the inactive metabolites are excreted in the milk of lactating rats at concentrations similar to those in the plasma. The molecular weight (about 337) is low enough that excretion into breast milk should also be expected. The effects of this exposure on a nursing infant are unknown. Because myelosuppression has occurred in animals (dogs and rats) exposed to doses at or below the EHE (1), and reversible thrombocytopenia (duration dependent) in adult humans, women taking linezolid should probably not breast feed.
Reference
Index
Q&A about Linezolid
Don't repost.
